pilocarpine has been researched along with Carcinogenesis in 1 studies
Pilocarpine: A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma.
(+)-pilocarpine : The (+)-enantiomer of pilocarpine.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nolan, E | 1 |
| Vaillant, F | 1 |
| Branstetter, D | 1 |
| Pal, B | 1 |
| Giner, G | 1 |
| Whitehead, L | 1 |
| Lok, SW | 1 |
| Mann, GB | 1 |
| Rohrbach, K | 1 |
| Huang, LY | 1 |
| Soriano, R | 1 |
| Smyth, GK | 1 |
| Dougall, WC | 1 |
| Visvader, JE | 1 |
| Lindeman, GJ | 1 |
1 other study available for pilocarpine and Carcinogenesis
| Article | Year |
|---|---|
RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
Topics: Animals; Bone Density Conservation Agents; BRCA1 Protein; Breast; Breast Neoplasms; Carcinogenesis; | 2016 |